MidAtlantic Capital Management Inc. Purchases Shares of 68 Intuitive Surgical, Inc. (NASDAQ:ISRG)

MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 68 shares of the medical equipment provider’s stock, valued at approximately $33,000.

Several other large investors also recently modified their holdings of the stock. Creekmur Asset Management LLC grew its stake in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth approximately $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. LRI Investments LLC bought a new position in shares of Intuitive Surgical during the first quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC lifted its holdings in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock valued at $45,897,071 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.8 %

ISRG opened at $531.64 on Tuesday. The company’s 50 day moving average is $500.33 and its 200-day moving average is $459.58. The company has a market cap of $189.36 billion, a P/E ratio of 85.47, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Citigroup upped their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Finally, Truist Financial lifted their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.